NEUPHORIA THERAPEUTICS INC.
NEUPHORIA THERAPEUTICS INC. is a registered legal entity registered in United States under 4102671, and its current status with Delaware Division of Corporations is active. The company was incorporated on 7 January 2024 and lists its registered address as United States. 1 shareholder is on record for NEUPHORIA THERAPEUTICS INC., and since every one of them is a company rather than an individual, this particular filing does not on its own establish an ultimate beneficial owner (UBO) — identifying one would mean tracing the ownership of each shareholding company in turn. This profile is sourced directly from Delaware Division of Corporations and was last updated on 21 October 2026.
- Company fundamentals
- Corporate linkage & group structures
- Digitized company financials
- Firmographics — websites, social profiles, revenue and employee estimates
Shareholders
1
One shareholder is currently on record for NEUPHORIA THERAPEUTICS INC., reflecting the stock ledger kept by the company under state corporate law (e.g. §219 of the Delaware General Corporation Law) rather than a public filing.
The largest of these is UBS Group AG, holding 0.6% — the largest recorded stake.
Because the shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
| Shareholder | Type | Holding | Source Document |
|---|---|---|---|
| UBS Group AG | 0.6% | Delaware Division of Corporations |
Officers
5
The Ceo, President & Executive Director of NEUPHORIA THERAPEUTICS INC. currently on record is Spyridon Papapetropoulos M.d., Ph.d.; five officers are currently on record for NEUPHORIA THERAPEUTICS INC., filed with Delaware Division of Corporations.
The register reports 9 officers in total, including past appointments, though only the 5 most relevant records are shown here.
Management authority at NEUPHORIA THERAPEUTICS INC. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
The source filing doesn't specify representation authority — whether officers can act individually or must sign jointly to bind the company — so that detail isn't available here.
Get complete shareholder and officer records, ultimate beneficial owner resolution, and ongoing ownership monitoring.
Frequently Asked Questions
Who owns NEUPHORIA THERAPEUTICS INC.?
One shareholder is currently on record for NEUPHORIA THERAPEUTICS INC., reflecting the stock ledger kept by the company under state corporate law (e.g. §219 of the Delaware General Corporation Law) rather than a public filing. The largest of these is UBS Group AG, holding 0.6% — the largest recorded stake. Because the shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
Who is NEUPHORIA THERAPEUTICS INC.'s UBO (Ultimate Beneficial Owner)?
Every shareholder recorded for NEUPHORIA THERAPEUTICS INC. is itself a company rather than a natural person, so no Ultimate Beneficial Owner (UBO) is identified at this level; establishing one would require tracing the ownership of each shareholding company in turn.
How many shareholders does NEUPHORIA THERAPEUTICS INC. have on record?
1 shareholder is shown on record for NEUPHORIA THERAPEUTICS INC..
What is NEUPHORIA THERAPEUTICS INC.'s company registration number?
NEUPHORIA THERAPEUTICS INC.'s registration number is 4102671, filed with Delaware Division of Corporations in United States. Its current status on the register is active.
Is NEUPHORIA THERAPEUTICS INC. still an active company?
NEUPHORIA THERAPEUTICS INC.'s status on Delaware Division of Corporations is listed as active.
When was NEUPHORIA THERAPEUTICS INC. incorporated?
NEUPHORIA THERAPEUTICS INC. was incorporated on 7 January 2024, according to Delaware Division of Corporations.
What is NEUPHORIA THERAPEUTICS INC.'s registered address?
The registered address on file for NEUPHORIA THERAPEUTICS INC. is United States.
Who are the officers/directors of NEUPHORIA THERAPEUTICS INC.?
The Ceo, President & Executive Director of NEUPHORIA THERAPEUTICS INC. currently on record is Spyridon Papapetropoulos M.d., Ph.d.; five officers are currently on record for NEUPHORIA THERAPEUTICS INC., filed with Delaware Division of Corporations. Management authority at NEUPHORIA THERAPEUTICS INC. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
Can Zavia monitor changes to NEUPHORIA THERAPEUTICS INC.'s ownership over time?
This profile reflects a point-in-time snapshot from Delaware Division of Corporations. Zavia's monitoring API can track changes to NEUPHORIA THERAPEUTICS INC.'s registered shareholders, officers, and group structure going forward, flagging updates as they're filed rather than requiring a manual recheck.
Can I access NEUPHORIA THERAPEUTICS INC.'s data through an API?
Yes. Zavia's API connects directly to official government ownership registries across 195 countries and territories, including United States, so records like NEUPHORIA THERAPEUTICS INC.'s registration, shareholder, UBO, and group-structure data can be queried programmatically instead of viewed one page at a time.
Where does this company information come from, and how current is it?
This record is sourced directly from Delaware Division of Corporations and was last synced on 21 October 2026.